10/10/2014 - 1:22pm

The Food and Drug Administration on Friday approved Akynzeo (netupitant and palonosetron) for the treatment of nausea and vomiting in patients who are undergoing cancer chemotherapy.

10/09/2014 - 2:49pm

Purdue Pharma on Thursday announced the launch of a new dosage strength of 7.5 mcg/hour for its Butrans (buprenorphine) transdermal system CIII, bringing the total number of strengths offered by the company to five.

10/09/2014 - 2:13pm

Salix Pharmaceuticals on Thursday announced that the Food and Drug Administration granted final approval for the company's Uceris (budesonide) rectal foam for patients with mild-to-moderate distal ulcerative colitis. 

10/09/2014 - 11:04am

Endo International and Auxilium Pharmaceuticals on Thursday announced that they have entered into a definitive agreement.

10/08/2014 - 10:47am

Teva Pharmaceutical Industries on Wednesday announced the initiation of a rolling new drug application submission for hydrocodone bitartrate extended-release tablets.

10/08/2014 - 9:04am

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

10/07/2014 - 11:52am

Actavis and Durata Therapeutics on Monday announced that they have entered into a definitive merger agreement.

10/07/2014 - 10:36am

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

10/06/2014 - 4:35pm

Specialty drug spending continues to rise and is predicted to grow by more than 16% annually from 2015 to 2018. CVS Health researchers examine the reasons for such dramatic increases in spending and discuss tools to help manage these escalating costs.